Biotechnology demands a new enabling role of the state in Korea. The pressure for system reconfiguration stems from the blurring of the boundaries between science and industry. A shift from a funding-oriented policy to regulatory governance is required. A framework is developed to describe latecomer system change as a co-evolutionary process.
The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the research contends that the Korean post-developmental state should be geared towards coordinating the interplay of technologies, modes of organization and institutions. An integrative framework is developed to describe system change as a co-evolutionary process in which the national and sectoral dimensions intersect. The case shows that the shaping of an environment in which innovation systems can develop sectoral transformative capacity is a central aspect of latecomer innovation governance.
Dirk Johann
2. national innovation system Ahrens Biotechnology co-evolution Dirk Governing Innov Innovation Joachim Johann Korea Latecomer Pharmaceutical post catch-up development Reconfig